Late treatment study
et al., Annals of Oncology, 31:10, 1386-1396, doi:10.1016/j.annonc.2020.06.007 (Peer Reviewed)
COVID-19 in patients with lung cancer
Analysis of hospitalized lung cancer patients with 35 of 48 taking HC
Q, mortality OR 1.03, p
death, ↑2.2%, p=0.99
(odds ratio converted to relative risk)
Please send us corrections, updates, or comments.